At a glance · for buyers and watchdogs
Tilomed has won £500.6m across 10 public-sector buyers, with 40 live contracts. No active Companies House risk flags.
Why: top buyer NHS England at 96% · 0 active risk flags · 0 modifications.
ESG & policies vault · 0/5
Key governance & sustainability policies. Published documents link out; missing ones are greyed.
Capabilities
What this supplier does, where they sit, who they sell to.
- NHS Framework Agreement for Branded medicines - National
- NHS National Branded Proprietary Products (Interim Agreement) - Contracts Finder Award
- Supportive Medicines including ITU, EOL & Antibiotics
- NHS National Pharmaceuticals Transition 2022_1
Extracted automatically from tillomed.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.
Case studies
Delivery stories the supplier has published, with sector and outcome.
No case studies yet
Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.
Buyer references
Named public-sector contacts who have agreed to act as a reference.
No buyer references yet
Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.
Accreditations & memberships
Independently issued. Verification dates cross-checked against issuer registers.
No accreditations recorded
B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.
KPI performance
Delivery, budget and satisfaction scores reported quarterly by buyers.
No verified KPI scores yet
Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.
Contracts · 40 live · 16 historic
Pulled from Contracts Finder & Find a Tender. Most recent first.
| Title | Buyer | CPV | Awarded | Value | Term | Status |
|---|---|---|---|---|---|---|
| NHS England | — | 01 Jun 2026 | £403.7m | 2 yrs | pending | |
| NHS England | — | 01 Feb 2026 | £21.6m | 1.7 yrs | pending | |
| NHS England | 33600000 | 01 Oct 2024 | £1.4m | 1.7 yrs | Closed | |
| NHS England | 33600000 | 01 May 2024 | £11.2m | 4 yrs | Live | |
| NHS England | 33600000 | 01 Jun 2024 | £0.02 | 3 yrs | Live | |
| NHS England | 33600000 | 01 Aug 2023 | £1.9m | 1.5 yrs | Closed | |
| NHS England | 33600000 | 01 May 2023 | £6.1m | 2 yrs | Closed | |
| NHS England | 33600000 | 01 Feb 2023 | £2.1m | 2 yrs | Closed | |
| NHS England and NHS Improvement | 33600000 | 29 Jul 2022 | £944k | 1.8 yrs | Closed | |
| NHS England | 33600000 | 01 May 2022 | £6.1m | 2 yrs | Closed |
Top buyers · 10 buyers · top 3 = 100%
Share of awarded value. Concentration fires above 40% for any single buyer.
Geography
Distribution of awarded value by buyer region.
Peers
Suppliers with overlapping CPVs & buyers (last 24m). Tilomed highlighted.
| Supplier | SME? | Awarded · 24m | Contracts |
|---|---|---|---|
TI Tilomed | No | £425.3m | — |
| Yes | £121.0m | 22 | |
| Yes | £117.6m | 18 | |
| Yes | £95.2m | 12 | |
| Yes | £72.5m | 12 | |
| Yes | £71.2m | 21 |
Red flags · 0 active
Automated scan of Companies House status, charges and insolvency records.
Compliance scorecard
Derived from Companies House filings — not a full supplier-assurance check.
Modifications
Variations to awarded contracts logged under Procurement Act 2023 s.74.
No modifications recorded
No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.
News mentions
UK trade press & nationals, matched to this supplier.
No news mentions found
We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.
Companies House
Live sync — registered details, directors, PSC and SIC codes.
Registered details
- Company no.
- 02544103
- Status
- Active
- Type
- Private limited
- Incorporated
- 28 Sept 1990
- Reg. office
- 220 Butterfield, Great Marlings, Luton, LU2 8DL
- SIC codes
- 46460
- Last accounts
- 31 Mar 2026
- Next accounts due
- 31 Dec 2027
Directors & PSC
- SRIMAL, Ajit Chand — directorAppointed 27 Jan 2025
- MEHTA, Samit Satish — directorAppointed 09 May 2018
- SHAIKH, Tajuddin — directorAppointed 18 Nov 2016
- Emcure Pharma Uk Ltd — person with significant controlownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors
Financial
Filed accounts from Companies House.
No financial filings on record
Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.
Org tree
Group structure and ownership.
Independent. No parent company or subsidiaries recorded at Companies House for this entity.
Social value
Commitments mapped to the Government Social Value Model themes.
No social-value commitments yet
Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.